• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Oliver Dorigo Discusses an Interdisciplinary Approach to Care in Gynecologic Oncology

Video

An interdisciplinary approach to patient care is very important because the treatment of gynecologic cancers can be very complex, explained Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.

An interdisciplinary approach to patient care is very important because the treatment of gynecologic cancers can be very complex, explained Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.

Transcript

How does your division at Stanford utilize an interdisciplinary approach to patient care?

An interdisciplinary approach to patient care, in my opinion, is very important since the treatment of gynecologic cancers can be very complex. Our patients are seen initially in our clinic, but upon diagnosis, they are then treated by an interdisciplinary team that does include the gynecologic oncologist, the radiation oncologist, radiologist, pathologist, and the palliative care service.

We nowadays believe that palliative care is a very important aspect of gynecologic cancer care from the very first beginning since we want to help patients with the diagnosis, the psychological aspect of having been diagnosed with cancer, and also side effects that are related to the treatment.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.